These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17182110)

  • 1. PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis.
    Carter LL; Leach MW; Azoitei ML; Cui J; Pelker JW; Jussif J; Benoit S; Ireland G; Luxenberg D; Askew GR; Milarski KL; Groves C; Brown T; Carito BA; Percival K; Carreno BM; Collins M; Marusic S
    J Neuroimmunol; 2007 Jan; 182(1-2):124-34. PubMed ID: 17182110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PD-1/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma.
    Cheng X; Zhao Z; Ventura E; Gran B; Shindler KS; Rostami A
    J Neuroimmunol; 2007 Apr; 185(1-2):75-86. PubMed ID: 17320975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE.
    Schreiner B; Bailey SL; Shin T; Chen L; Miller SD
    Eur J Immunol; 2008 Oct; 38(10):2706-17. PubMed ID: 18825752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis.
    Zhu B; Guleria I; Khosroshahi A; Chitnis T; Imitola J; Azuma M; Yagita H; Sayegh MH; Khoury SJ
    J Immunol; 2006 Mar; 176(6):3480-9. PubMed ID: 16517716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis.
    Salama AD; Chitnis T; Imitola J; Ansari MJ; Akiba H; Tushima F; Azuma M; Yagita H; Sayegh MH; Khoury SJ
    J Exp Med; 2003 Jul; 198(1):71-8. PubMed ID: 12847138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells.
    Latchman YE; Liang SC; Wu Y; Chernova T; Sobel RA; Klemm M; Kuchroo VK; Freeman GJ; Sharpe AH
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10691-6. PubMed ID: 15249675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation.
    Kuipers H; Muskens F; Willart M; Hijdra D; van Assema FB; Coyle AJ; Hoogsteden HC; Lambrecht BN
    Eur J Immunol; 2006 Sep; 36(9):2472-82. PubMed ID: 16917960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of programmed death-1 (PD-1)/PD-1 ligands pathway in the development of murine acute myocarditis caused by coxsackievirus B3.
    Seko Y; Yagita H; Okumura K; Azuma M; Nagai R
    Cardiovasc Res; 2007 Jul; 75(1):158-67. PubMed ID: 17434153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-1-PD-L1 pathway impairs T(h)1 immune response in the late stage of infection with Mycobacterium bovis bacillus Calmette-Guérin.
    Sakai S; Kawamura I; Okazaki T; Tsuchiya K; Uchiyama R; Mitsuyama M
    Int Immunol; 2010 Dec; 22(12):915-25. PubMed ID: 21047981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of programmed death 1 and its ligands in the liver of autoimmune hepatitis C57BL/6 mice.
    Cao J; Liu FX; Yu MX
    Chin Med J (Engl); 2009 Aug; 122(16):1941-6. PubMed ID: 19781375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-programmed cell death 1 antibody reduces CD4+PD-1+ T cells and relieves the lupus-like nephritis of NZB/W F1 mice.
    Kasagi S; Kawano S; Okazaki T; Honjo T; Morinobu A; Hatachi S; Shimatani K; Tanaka Y; Minato N; Kumagai S
    J Immunol; 2010 Mar; 184(5):2337-47. PubMed ID: 20139271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis.
    Raptopoulou AP; Bertsias G; Makrygiannakis D; Verginis P; Kritikos I; Tzardi M; Klareskog L; Catrina AI; Sidiropoulos P; Boumpas DT
    Arthritis Rheum; 2010 Jul; 62(7):1870-80. PubMed ID: 20506224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
    Imler TJ; Petro TM
    Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes.
    Won TJ; Jung YJ; Kwon SJ; Lee YJ; Lee DI; Min H; Park ES; Joo SS; Hwang KW
    Arch Pharm Res; 2010 Nov; 33(11):1825-33. PubMed ID: 21116786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1/PD-1 signal deficiency promotes allogeneic immune responses and accelerates heart allograft rejection.
    Wang W; Carper K; Malone F; Latchman Y; Perkins J; Fu Y; Reyes J; Li W
    Transplantation; 2008 Sep; 86(6):836-44. PubMed ID: 18813109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-1 deletion restores susceptibility to experimental autoimmune encephalomyelitis in miR-155-deficient mice.
    Zhang J; Braun MY
    Int Immunol; 2014 Jul; 26(7):407-15. PubMed ID: 24648472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.
    Butte MJ; Keir ME; Phamduy TB; Sharpe AH; Freeman GJ
    Immunity; 2007 Jul; 27(1):111-22. PubMed ID: 17629517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses.
    Liang SC; Latchman YE; Buhlmann JE; Tomczak MF; Horwitz BH; Freeman GJ; Sharpe AH
    Eur J Immunol; 2003 Oct; 33(10):2706-16. PubMed ID: 14515254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: implications for the lesion pathogenesis of multiple sclerosis.
    Ortler S; Leder C; Mittelbronn M; Zozulya AL; Knolle PA; Chen L; Kroner A; Wiendl H
    Eur J Immunol; 2008 Jun; 38(6):1734-44. PubMed ID: 18421793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressed T-cell activation by IFN-gamma-induced expression of PD-L1 on renal tubular epithelial cells.
    Schoop R; Wahl P; Le Hir M; Heemann U; Wang M; Wüthrich RP
    Nephrol Dial Transplant; 2004 Nov; 19(11):2713-20. PubMed ID: 15353579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.